Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell’s Virtual Claims Workflow for the Connected Consumer
Today's connected consumers tend to have a higher expectation of self-service options.
PDF
Article
Virtual Connections
Mitchell
News Release
Industrial Commission of Arizona Adopts New Pharmacy and Physician Fee Schedules
The Industrial Commission of Arizona (ICA) recently posted the newly adopted pharmaceutical and physician fee schedules for 2019-2020.
Mitchell
News Release
Mitchell Issues 3rd Quarter 2019 Industry Trends Report
San Diego, CA—Mitchell Internati
Workers' Comp
Blog
Morphine Equivalent Dose (MED) Trends in 2018
Morphine Equivalent Dose (MED) remains a valuable indicator of risk when it comes to opioids, and we continue to see downward trends through 2018 that
Workers' Comp
News Release
Risk & Insurance: Better Recovery Outcomes Are Built on Trust, Says This Nurse Case Manager
British socialite-turned-nurse Floren